The FDA is backing a new “qualified health claim” that oils high in oleic acid can help improve cholesterol levels and protect against coronary heart disease, Commissioner Scott Gottlieb, MD, announced Nov. 19.

Despite recent actions by the Centers for Medicare and Medicaid Services (CMS) to remove restrictions around MRIs for heart patients with implantable cardiovascular devices, the U.S. government is failing to protect a subset of those patients with fractured, epicardial or abandoned leads, according to an editorial published in JAMA Cardiology this November.

Diabetics who have transitioned to an employer-mandated, high-deductible insurance plan are significantly more likely to delay healthcare visits for macrovascular symptoms, diagnostic tests and procedures, researchers reported Nov. 20 in the Annals of Internal Medicine.

More than half of personal healthcare information (PHI) data breaches in recent history can be traced back to healthcare providers themselves rather than hackers or external parties, researchers reported in JAMA Internal Medicine.

In a back-to-the-future move, a decades-old care delivery concept is gaining momentum.

It’s becoming evident that the Stark law is frustrating the move from volume to value. Experts expect changes that could allow health systems and practices to deploy better coordinated, team-based care and advanced alternative payment models.

Violence, an ever-growing presence in our global communities, isn’t just a social issue, according to research presented at the American Heart Association’s annual Scientific Sessions in Chicago Nov. 12. It’s a public health one, too, and it can have serious consequences for our heart health.

The FDA plans to take aggressive steps toward limiting youth access to tobacco products and banning the sale of flavored nicotine, the organization’s commissioner, Scott Gottlieb, MD, has announced in a statement.